VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ history of significant bleeding (i.e. bleeding     │ history of significant bleeding (i.e. bleeding     │     100 │
│ which required intervention or hospitalization),   │ which required intervention or hospitalization),   │         │
│ even in the absence of anticoagulation treatment   │ even in the absence of anticoagulation treatment   │         │
│ at the time of the bleeding event, or              │ at the time of the bleeding event, or              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ a cardioembolic event, which occurred on           │ a cardioembolic event, which occurred on           │     100 │
│ anticoagulation, or                                │ anticoagulation, or                                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ thrombus in the LA or LAA                          │ thrombus in the LA or LAA                          │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ mechanical valve prosthesis                        │ mechanical valve prosthesis                        │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ mitral stenosis                                    │ mitral stenosis                                    │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ previous LAA ligation during cardiac surgery       │ previous LAA ligation during cardiac surgery       │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ life expectancy less than 2 years                  │ life expectancy less than 2 years                  │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ comorbidities other than AF, which present an      │ comorbidities other than AF, which present an      │     100 │
│ indication for anticoagulation                     │ indication for anticoagulation                     │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ patent foramen ovale with atrial septal aneurysm   │ patent foramen ovale with atrial septal aneurysm   │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ mobile plaque in the aorta                         │ mobile plaque in the aorta                         │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ symptomatic atherosclerosis of the carotid artery  │ symptomatic atherosclerosis of the carotid artery  │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ pericardial effusion greater than 10 mm            │ pericardial effusion greater than 10 mm            │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ clinically significant bleeding within the 30 days │ clinically significant bleeding within the 30 days │     100 │
│ prior to the scheduled procedure                   │ prior to the scheduled procedure                   │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ stroke or other cardioembolic event within the 30  │ stroke or other cardioembolic event within the 30  │     100 │
│ days prior to the scheduled procedure              │ days prior to the scheduled procedure              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ acute coronary syndrome within the 90 days prior   │ acute coronary syndrome within the 90 days prior   │     100 │
│ to the scheduled procedure                         │ to the scheduled procedure                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ gravidity                                          │ gravidity                                          │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ significant valvular disease                       │ significant valvular disease                       │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ creatinine clearance less than 30 ml/min           │ creatinine clearance less than 30 ml/min           │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ a high risk profile of the patient, defined as a   │ a high risk profile of the patient, defined as a   │      98 │
│ CHA2DS2-VASc score ≥ 3 and a HAS-BLED score ≥ 2    │ CHA2DS2-VASc score = 3 and a HAS-BLED score = 2    │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤═════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria               │   Score │
╞═══════════════════════════════════╪═════════════════════════════╪═════════╡
│ Must have minimum age of 18 Years │ mechanical valve prosthesis │      37 │
╘═══════════════════════════════════╧═════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 98
Average Levenshtein Ratio of individual lines: 96.75
OverAll Ratio: 97.375
